These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 30580131)
1. The prognostic value of various biomarkers in adults with pulmonary hypertension; a multi-biomarker approach. Geenen LW; Baggen VJM; Koudstaal T; Boomars KA; Eindhoven JA; Boersma E; Roos-Hesselink JW; van den Bosch AE Am Heart J; 2019 Feb; 208():91-99. PubMed ID: 30580131 [TBL] [Abstract][Full Text] [Related]
2. Exploring the Prognostic Value of Novel Markers in Adults With a Systemic Right Ventricle. Geenen LW; van Grootel RWJ; Akman K; Baggen VJM; Menting ME; Eindhoven JA; Cuypers JAAE; Boersma E; van den Bosch AE; Roos-Hesselink JW J Am Heart Assoc; 2019 Sep; 8(17):e013745. PubMed ID: 31431113 [TBL] [Abstract][Full Text] [Related]
3. Galectin-3 Levels Are Elevated and Predictive of Mortality in Pulmonary Hypertension. Mazurek JA; Horne BD; Saeed W; Sardar MR; Zolty R Heart Lung Circ; 2017 Nov; 26(11):1208-1215. PubMed ID: 28242288 [TBL] [Abstract][Full Text] [Related]
4. A multimarker multi-time point-based risk stratification strategy in acute heart failure: results from the RELAX-AHF trial. Demissei BG; Cotter G; Prescott MF; Felker GM; Filippatos G; Greenberg BH; Pang PS; Ponikowski P; Severin TM; Wang Y; Qian M; Teerlink JR; Metra M; Davison BA; Voors AA Eur J Heart Fail; 2017 Aug; 19(8):1001-1010. PubMed ID: 28133908 [TBL] [Abstract][Full Text] [Related]
5. Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death. Apple FS; Murakami MM; Pearce LA; Herzog CA Clin Chem; 2004 Dec; 50(12):2279-85. PubMed ID: 15364888 [TBL] [Abstract][Full Text] [Related]
6. The role of timely measurement of galectin-3, NT-proBNP, cystatin C and hsTnT in predicting prognosis and heart function after heart transplantation. Franeková J; Hošková L; Sečník P; Pazderník M; Kotrbatá M; Kubíček Z; Jabor A Clin Chem Lab Med; 2016 Feb; 54(2):339-44. PubMed ID: 26351922 [TBL] [Abstract][Full Text] [Related]
8. Growth differentiation factor-15 as candidate predictor for mortality in adults with pulmonary hypertension. Geenen LW; Baggen VJM; Kauling RM; Koudstaal T; Boomars KA; Boersma E; Roos-Hesselink JW; van den Bosch AE Heart; 2020 Mar; 106(6):467-473. PubMed ID: 31492701 [TBL] [Abstract][Full Text] [Related]
9. MR-proADM Predicts Exercise Capacity and Survival Superior to Other Biomarkers in PH. Kolditz M; Seyfarth HJ; Wilkens H; Ewert R; Bollmann T; Dinter C; Hertel S; Klose H; Opitz C; Grünig E; Höffken G; Halank M Lung; 2015 Dec; 193(6):901-10. PubMed ID: 26363916 [TBL] [Abstract][Full Text] [Related]
10. Targeted multiple biomarker approach in predicting cardiovascular events in patients with diabetes. Resl M; Clodi M; Vila G; Luger A; Neuhold S; Wurm R; Adlbrecht C; Strunk G; Fritzer-Szekeres M; Prager R; Pacher R; Hülsmann M Heart; 2016 Dec; 102(24):1963-1968. PubMed ID: 27456261 [TBL] [Abstract][Full Text] [Related]
11. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure. de Antonio M; Lupon J; Galan A; Vila J; Urrutia A; Bayes-Genis A Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860 [TBL] [Abstract][Full Text] [Related]
12. Association of Multiple Biomarkers With Risk of All-Cause and Cause-Specific Mortality After Acute Coronary Syndromes: A Secondary Analysis of the PLATO Biomarker Study. Lindholm D; James SK; Gabrysch K; Storey RF; Himmelmann A; Cannon CP; Mahaffey KW; Steg PG; Held C; Siegbahn A; Wallentin L JAMA Cardiol; 2018 Dec; 3(12):1160-1166. PubMed ID: 30427997 [TBL] [Abstract][Full Text] [Related]
13. B-type natriuretic peptide as a parameter for pulmonary hypertension in children. A systematic review. Ten Kate CA; Tibboel D; Kraemer US Eur J Pediatr; 2015 Oct; 174(10):1267-75. PubMed ID: 26298682 [TBL] [Abstract][Full Text] [Related]
14. Prospective Validation of a Screening Biomarker Approach Combining Amino-Terminal Pro-Brain Natriuretic Peptide With Galectin-3 Predicts Death and Cardiovascular Events in Asymptomatic Hemodialysis Patients. Voroneanu L; Siriopol D; Apetrii M; Hogas S; Onofriescu M; Nistor I; Kanbay M; Dumea R; Cusai S; Cianga P; Constantinescu D; Covic A Angiology; 2018 May; 69(5):449-455. PubMed ID: 28974104 [TBL] [Abstract][Full Text] [Related]
15. Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study. Bosello S; De Luca G; Berardi G; Canestrari G; de Waure C; Gabrielli FA; Di Mario C; Forni F; Gremese E; Ferraccioli G Eur J Intern Med; 2019 Feb; 60():46-53. PubMed ID: 30366614 [TBL] [Abstract][Full Text] [Related]
16. Usefulness of red cell distribution width as a prognostic marker in pulmonary hypertension. Hampole CV; Mehrotra AK; Thenappan T; Gomberg-Maitland M; Shah SJ Am J Cardiol; 2009 Sep; 104(6):868-72. PubMed ID: 19733726 [TBL] [Abstract][Full Text] [Related]
17. N-Terminal Pro-Brain Natriuretic Peptide Is Associated with a Future Diagnosis of Cancer in Patients with Coronary Artery Disease. Tuñón J; Higueras J; Tarín N; Cristóbal C; Lorenzo Ó; Blanco-Colio L; Martín-Ventura JL; Huelmos A; Alonso J; Aceña Á; Pello A; Carda R; Asensio D; Mahíllo-Fernández I; López Bescós L; Egido J; Farré J PLoS One; 2015; 10(6):e0126741. PubMed ID: 26046344 [TBL] [Abstract][Full Text] [Related]